Neoadjuvant endocrine therapy use in early stage breast cancer during the covid-19 pandemic

PURPOSE: Physician treatment preferences for early stage, estrogen positive breast cancer (ER + BC) patients were evaluated during the initial surge of the COVID-19 pandemic in the US when neoadjuvant endocrine therapy (NET) was recommended to allow safe deferral of surgery. METHODS: A validated ele...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Breast Cancer Res Treat
Autores principales: Park, Ko Un, Gregory, Megan, Bazan, Joey, Lustberg, Maryam, Rosenberg, Shoshana, Blinder, Victoria, Sharma, Priyanka, Pusztai, Lajos, Shen, Chengli, Partridge, Ann, Thompson, Alastair
Formato: Artigo
Lenguaje:Inglês
Publicado: Springer US 2021
Materias:
Epidemiology
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7921279/
https://ncbi.nlm.nih.gov/pubmed/33651271
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-021-06153-3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares